Medtronic's $200M Mounds View Expansion to Add 300 Insulin Pump Jobs

Medtronic plc, the Fridley-based medical device giant, announced a $200 million investment to expand its manufacturing facility in Mounds View, Minnesota, initially reported by Bring Me The News. The project will create 300 jobs over the coming years, centered on production of insulin pumps critical for diabetes management. Mounds View, in Ramsey County north of the Twin Cities, hosts the site's focus on high-tech diabetes devices, reinforcing Minnesota's status as a global med-tech leader with over 30,000 jobs in the sector. The expansion comes at a pivotal moment for Medtronic's Diabetes business. On May 21, 2025, the company revealed plans to separate the unit into a standalone entity via an initial public offering and split-off, targeted for completion within 18 months—potentially by November 2026—subject to market conditions and regulatory approvals[2]. This new Diabetes Company will retain the insulin pump portfolio, pipeline, intellectual property, and global manufacturing sites, including Mounds View, positioning it as the sole provider of a complete intensive insulin management ecosystem[2]. Despite broader challenges, including 220 U.S. layoffs in cardiac rhythm management announced in early May 2026[4], the Mounds View initiative signals growth in diabetes care. Job listings show 97 Medtronic openings in Mounds View as of May 2026, including assembler and engineering roles[1]. Minnesota officials, including Ramsey County Commissioners, praised the move for sustaining high-wage jobs—averaging $80,000 annually in med-tech—and supporting the state's 1 in 10 residents living with diabetes.